Search results for "Highlights"
Drug-eluting stents may not confer advantage in diabetic patients
An editorial noted that drug-eluting stents may work for noncomplex lesions in patients with diabetes, but complex disease states incurred high rates of myocardial infarction and revascularization.
https://diabetes.acponline.org/archives/2019/01/11/3.htm
11 Jan 2019
Insulin initiation in the hospital associated with death, ED visits, readmissions in older patients
The study authors noted that older patients who begin insulin therapy while hospitalized are a vulnerable population for whom additional resources are needed during the transition to outpatient care.
https://diabetes.acponline.org/archives/2019/03/08/2.htm
8 Mar 2019
Early subspecialist involvement led to reduced infections among inpatients with diabetes
Researchers studied an early intervention model in which an inpatient diabetes team electronically identified patients with hyperglycemia and aimed to provide bedside management within 24 hours of admission, compared with a referral-based consultation service.
https://diabetes.acponline.org/archives/2019/04/05/3.htm
5 Apr 2019
SGLT2 inhibitors, GLP-1 receptor agonists compared for CV, renal outcomes
Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with fewer hospitalizations for heart failure and slower progression of kidney disease while glucagon-like peptide-1 (GLP-1) receptor agonists were associated with lower risk of stroke.
https://diabetes.acponline.org/archives/2019/03/08/3.htm
8 Mar 2019
Cardiovascular event rates similar among newer second-line medications for type 2 diabetes
The comparison of dipeptidyl peptidase-4 inhibitors with other drug classes did find higher rates of major adverse cardiovascular events with basal insulin, sulfonylureas, and meglitinides than with the newer drugs.
https://diabetes.acponline.org/archives/2019/01/11/2.htm
11 Jan 2019
Poor glycemic control associated with fracture in type 1 but not type 2 diabetes
Patients with type 1 diabetes and a mean three-year HbA1c level greater than 8.0% had a higher fracture risk than those with a mean three-year HbA1c level of 7.0% or less.
https://diabetes.acponline.org/archives/2019/02/08/3.htm
8 Feb 2019
Sulfonylureas not supported as second-line treatment for type 2 diabetes
Risk for major adverse cardiovascular events and all-cause mortality was higher when a sulfonylurea was added to metformin compared to other typical second- or third-line therapy options in a recent Danish study.
https://diabetes.acponline.org/archives/2020/04/10/1.htm
10 Apr 2020
Glycemic control worse over time in type 2 patients who decline insulin, study finds
In adults with uncontrolled type 2 diabetes who initially declined insulin versus those who initially accepted, median time to an HbA1c level below 7.0% was 50 months versus 38 months.
https://diabetes.acponline.org/archives/2020/03/13/1.htm
13 Mar 2020
AHA issues statement on coronary artery disease management in patients with diabetes
The American Heart Association (AHA) addressed use of antithrombotics, hypertension drugs, and cholesterol therapies in patients with stable coronary artery disease and diabetes, among other recommendations.
https://diabetes.acponline.org/archives/2020/05/08/1.htm
8 May 2020
3 actions may help reluctant patients begin insulin therapy for type 2 diabetes
Patients' perceived helpfulness of certain actions by health care professionals was linked to earlier insulin initiation and greater insulin continuation over time, a survey found.
https://diabetes.acponline.org/archives/2019/02/08/2.htm
8 Feb 2019